New fusion peptide comprising a coupling of a silencing domain with small molecule peptide aptamer, is androgen receptor inhibitor, useful to treat prostate cancer and benign prostatic hyperplasia

Fusion peptide (I) comprising a coupling of a silencing domain with small molecule peptide aptamer, for the inhibition of androgen receptor, is new. - ACTIVITY : Cytostatic. - MECHANISM OF ACTION : Androgen receptor inhibitor.

Attached files:
102008014882.jpg

Patents:
DE 102,008,014,882

Type of Offer: Sale



« More Biotech Patents

Share on      


CrowdSell Your Patent